Evaluation of growth promotion and inhibition from mycobactins and nonmycobacterial siderophores (Desferrioxamine and FR160) in Mycobacterium aurum

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 8, 1997, Pages 1837-1839

  Bosne David, S ^a   Bricard, L ^b   Ramiandrasoa, F ^b   DeRoussent A ^c   Kunesch, G ^b   Andremont, A ^d  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b CNRS   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; DEFEROXAMINE MESYLATE; FR 160; MYCOBACTIN; N4 NONYL N1,N8 BIS(2,3 DIHYDROXYBENZOYL)SPERMIDINE; SIDEROPHORE; SPERMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; MYCOBACTERIUM; MYCOBACTERIUM AURUM; NONHUMAN; PRIORITY JOURNAL;

EID: 0030855151     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.8.1837     Document Type: Article

References (30)

1. Barclay, R., and C. Ratledge. 1986. Participation of iron in the growth inhibition of pathogenic strains of Mycobacterium avium and M. paratuberculosis in serum. Zentralbl. Bakteriol. Mikrobiol. Hyg. Ser. A 262:189-194.
2. Basker, M. J., R. A. Edmondson, S. J. Knott, R. J. Ponsford, B. Slocombe, and S. J. White. 1984. In vitro antibacterial properties of BRL 36650, a novel 6α-substituted penicillin. Antimicrob. Agents Chemother. 26:734-740.
3. Basker, M. J., C. H. Frydrych, F. P. Harrington, and P. H. Milner. 1989. Antibacterial activity of catecholic piperacillin analogues. J. Antibiot. 42: 1328-1330.
4. Bosne, S., F. Papa, S. Clavel-Sérès, and N. Rastogi. 1993. A simple and reliable EDDA method for mycobactin production in mycobacteria: optimal conditions and use in mycobacterial speciation. Curr. Microbiol. 26:353-358.
5. Bricard, L., C. Loubeyre, F. Ramiandrasoa, G. Kunesch, A. Gaudemer, and A. Andremont. May 1994. Brevet d'invention no. 9405792. Nouveaux dérivés de la pristinamycine, leur préparation et les compositions pharmaceutiques qui les contiennent. Rhône-Poulenc-Rorer S.A.
6. David, H. L. 1981. Basis for lack of drug susceptibility of atypical mycobacteria. Rev. Infect. Dis. 3:878-884.
7. Dionis, J. B., H.-B. Jenny, and H. H. Peter. 1991. Therapeutically useful iron chelators, p. 339-356. In G. Winkelmann (ed.), Handbook of microbial iron chelates. CRC Press, Boca Raton, Fla.
8. Francis, J., H. M. Mackturk, J. Madinaveitia, and G. A. Snow. 1953. Mycobactin, a growth factor for Mycobacterium johnei. I. Isolation from Mycobacterium phlei. Biochem. J. 55:596-607.
9. Kochan, I., D. L. Cahall, and C. A. Golden. 1971. Employment of tuberculostasis in serum-agar medium for the study of production and activity of mvcobactin. Infect. Immun. 4:130-137.
10. Kochan, I., N. R. Pellis, and C. A. Golden. 1971. Mechanism of tuberculostasis in mammalian serum. III. Neutralization of serum tuberculostasis by mycobactin. Infect. Immun. 3:553-558.
11. Merkal, R. S., and W. J. McCullough. 1982: A new mycobactin, mycobactin J. from Mycobacterium paratuberculosis. Curr. Microbiol. 7:333-335.
12. Miller, M. J., and F. Malouin. 1993. Microbial iron chelators as drug delivery agents: the rational design and synthesis of siderophore drug conjugates. Acc. Chem. Res. 26:241-249.
13. Miller, M. J., and F. Malouin. 1994. Siderophore-mediated drug delivery: the design, synthesis, and study of siderophore-antibiotic and antifungal conjugates, p. 275-306. In R. J. Bergeron and G. M. Brittenham (ed.), The development of iron chelators for clinical use. CRC Press, Boca Raton, Fla.
14. Ohi, N., B. Aoki, T. Shinozaki, K. Moro, T. Noto, T. Nehashi, H. Okasaki, and I. Matsunaga. 1986. Semisynthetic β-lactam antibiotics. I. Synthesis and antibacterial activity of new ureidopenicillin derivatives having catechol moieties. J. Antibiot. 39:230-241.
15. Ohi, N., B. Aoki, T. Shinozaki, K. Moro, T. Kuroki, T. Noto, T. Nehashi, M. Matsumoto, H. Okasaki, and I. Matsunaga. 1987. Semisynthetic β-lactam antibiotics. IV. Synthesis and antibacterial activity of new ureidocephalosporin and ureidocephamycin derivatives containing a catechol moiety or its acetate. Chem. Pharm. Bull. (Tokyo) 35:1903-1909.
16. Ong, S. A., T. Peterson, and J. B. Neilands. 1979. Agrobactin, a siderophore from Agrobacterium tumefaciens. J. Biol. Chem. 254:1860-1865.
17. Pradines, B., F. Ramiandrasoa, L. K. Basco, L. Bricard, G. Kunesch, and J. Le Bras. 1996. In vitro activity of novel catecholate siderophores against Plasmodium falciparum. Antimicrob. Agents Chemother. 40:2094-2098.
18. Pradines, B., L. K. Basco, and J. Le Bras. 1994. In vitro antimalarial potency of novel catechol siderophores, p. 139. In Medicinal chemistry. Proceedings of the XIIIth International Symposium. Palais de Congrès, Paris, France.
19. Rastogi, N., B. Moreau, M. L. Capmau, K. S. Goh, and H. L. David. 1988. Antibacterial action of amphipathic derivatives of isoniazid against the Mycobacterium avium complexe. Zentralbl. Bakteriol. Mikrobiol. Hyg. Ser. A 268:456-462.
20. Ratledge, C. 1982. Nutrition, growth and metabolism, p. 186-212. In C. Ratledge and J. Stanford (ed.), The biology of the mycobacteria. Academic Press Ltd., London, England.
21. Rogers, H. J. 1973. Iron-binding catechols and virulence in Escherichia coli. Infect. Immun. 7:445-456.
22. Sharman, G. J., D. H. Williams, D. F. Ewing, and C. Ratledge. 1995. Isolation, purification and structure of exochelin MS, the extracellular siderophore from Mycobacterium smegmatis. Biochem. J. 305:187-196.
23. Silley, P., J. W. Griffiths, D. Monsey, and A. M. Harris. 1990. Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tonB-dependent iron transport system. Antimicrob. Agents Chemother. 34:1806-1808.
24. Snow, G. A. 1965. The structure of mycobactin P, a growth factor for Mycobacterium johnei, and the significance of its iron complex. Biochem. J. 94: 160-165.
25. Snow, G. A. 1970. Mycobactins: iron-chelating growth factors from mycobacteria. Bacteriol. Rev. 34:99-125.
26. Stephenson, M. C., and C. Ratledge. 1979. Iron transport in Mycobacterium smegmatis: uptake of iron from ferriexochelin. J. Gen. Microbiol. 110:193-202.
27. Watanabe, N.-A., T. Nagasu, K. Katsu, and K. Kitoh. 1987. E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system. Antimicrob. Agents Chemother. 31:497-504.
28. Wells, H. G., and E. R. Long. 1932. The chemistry of tuberculosis. The Williams and Wilkins Company. Baltimore, Md.
29. Woodley, C. L., and H. L. David. 1976. Effect of temperature on the rate of the transparent to opaque colony type transition in Mycobacterium avium. Antimicrob. Agents Chemother. 9:113-119.
30. World Health Organization. 1996. Report WHO/22, March 21. World Health Organization, Geneva, Switzerland.